Dive C - Search Results

1

Circulating tumour cells: their utility in cancer management and predicting outcomes.

Krebs MG, Hou JM, Ward TH, Blackhall FH, Dive C. Krebs MG, et al. Among authors: dive c. Ther Adv Med Oncol. 2010 Nov;2(6):351-65. doi: 10.1177/1758834010378414. Ther Adv Med Oncol. 2010. PMID: 21789147 Free PMC article.

2

Apoptosis pathway-targeted drugs--from the bench to the clinic.

Cummings J, Ward TH, Ranson M, Dive C. Cummings J, et al. Among authors: dive c. Biochim Biophys Acta. 2004 Dec 10;1705(1):53-66. doi: 10.1016/j.bbcan.2004.09.005. Biochim Biophys Acta. 2004. PMID: 15585173 Review.

3

Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.

Cummings J, Ward TH, LaCasse E, Lefebvre C, St-Jean M, Durkin J, Ranson M, Dive C. Cummings J, et al. Among authors: dive c. Br J Cancer. 2005 Feb 14;92(3):532-8. doi: 10.1038/sj.bjc.6602363. Br J Cancer. 2005. PMID: 15685240 Free PMC article.

4

Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic.

Dean EJ, Ranson M, Blackhall F, Holt SV, Dive C. Dean EJ, et al. Among authors: dive c. Cancer Treat Rev. 2007 Apr;33(2):203-12. doi: 10.1016/j.ctrv.2006.11.002. Epub 2007 Jan 8. Cancer Treat Rev. 2007. PMID: 17210228 Review.

5

Biomarker method validation in anticancer drug development.

Cummings J, Ward TH, Greystoke A, Ranson M, Dive C. Cummings J, et al. Among authors: dive c. Br J Pharmacol. 2008 Feb;153(4):646-56. doi: 10.1038/sj.bjp.0707441. Epub 2007 Sep 17. Br J Pharmacol. 2008. PMID: 17876307 Free PMC article. Review.

6

X-linked inhibitor of apoptosis protein as a therapeutic target.

Dean EJ, Ranson M, Blackhall F, Dive C. Dean EJ, et al. Among authors: dive c. Expert Opin Ther Targets. 2007 Nov;11(11):1459-71. doi: 10.1517/14728222.11.11.1459. Expert Opin Ther Targets. 2007. PMID: 18028010 Review.

7

Optimisation of circulating biomarkers of cell death for routine clinical use.

Greystoke A, Cummings J, Ward T, Simpson K, Renehan A, Butt F, Moore D, Gietema J, Blackhall F, Ranson M, Hughes A, Dive C. Greystoke A, et al. Among authors: dive c. Ann Oncol. 2008 May;19(5):990-5. doi: 10.1093/annonc/mdn014. Epub 2008 Feb 27. Ann Oncol. 2008. PMID: 18304966 Free article.

8

Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity.

Cummings J, Hodgkinson C, Odedra R, Sini P, Heaton SP, Mundt KE, Ward TH, Wilkinson RW, Growcott J, Hughes A, Dive C. Cummings J, et al. Among authors: dive c. Mol Cancer Ther. 2008 Mar;7(3):455-63. doi: 10.1158/1535-7163.MCT-07-2136. Mol Cancer Ther. 2008. PMID: 18347133

9

Quantitative multiplexed quantum dot immunohistochemistry.

Sweeney E, Ward TH, Gray N, Womack C, Jayson G, Hughes A, Dive C, Byers R. Sweeney E, et al. Among authors: dive c. Biochem Biophys Res Commun. 2008 Sep 19;374(2):181-6. doi: 10.1016/j.bbrc.2008.06.127. Epub 2008 Jul 11. Biochem Biophys Res Commun. 2008. PMID: 18621021

10

Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer.

Board RE, Williams VS, Knight L, Shaw J, Greystoke A, Ranson M, Dive C, Blackhall FH, Hughes A. Board RE, et al. Among authors: dive c. Ann N Y Acad Sci. 2008 Aug;1137:98-107. doi: 10.1196/annals.1448.020. Ann N Y Acad Sci. 2008. PMID: 18837931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

429 results

Search Page